Key points are not available for this paper at this time.
UC-MSC cells plus DMARDs therapy can be a safe, effective and feasible therapeutic option for RA patients.
Wang et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: